about
SCCRO promotes glioma formation and malignant progression in miceIn vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studiesAntigen-specific immunotherapy of cervical and ovarian cancerUtilizing past and present mouse systems to engineer more relevant pancreatic cancer modelsLoss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesisDW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastomaAssessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion.Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectorsSomatic genetics empowers the mouse for modeling and interrogating developmental and disease processes.Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene deliveryUse of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.Modeling resistance to pathway-targeted therapy in ovarian cancerLentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancerHow genetically engineered mouse tumor models provide insights into human cancersCell-specific transduction of Prdm1-expressing lineages mediated by a receptor for avian leukosis virus subgroup BLow Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial LineageAkt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.Matching mice to malignancy: molecular subgroups and models of medulloblastoma.Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway in human TGW-nu-I neuroblastoma cells.The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancerThe absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma.Continuous cell supply from Krt7-expressing hematopoietic stem cells during native hematopoiesis revealed by targeted in vivo gene transfer method.Trp53 deletion stimulates the formation of metastatic pancreatic tumors.Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model.
P2860
Q24633442-04150761-58DE-4921-8105-B6ACA8B28B91Q26820289-0F7255DA-B0F2-4DBB-A73E-23E44B73173FQ27488697-1E455D84-DAED-46A1-8775-E78455CF4F21Q28083091-E00A4615-588C-47F3-ACAF-39D670B5A70DQ28584911-36C49BDE-F022-4B7E-9235-B148A7C10C6FQ28730443-2F8839EB-E480-4D44-88BB-CD07AA1EE859Q33302948-A5BD7A8A-7991-4AE2-833F-500211377FFBQ33912022-4AC5ED7F-FDFF-4395-9057-2B79411674F5Q33981293-D6CF1806-FD3C-4410-B0EB-F7BB609746DEQ34110178-737DE074-BBEE-4247-9B4B-E4E14E690C16Q34134454-1BE79DB4-028E-4580-949E-F8A9837F1B19Q34580042-A9CFCABA-6B76-4FB4-AB9D-DF50166641C7Q35067274-62029D53-FAF2-4506-908E-D2F49D8022CEQ35148115-7DEBCC74-13CD-4581-B65A-EB26DA20C90EQ35170696-3B407D23-FA7A-4E7A-A56A-61961C8C6E24Q35689762-8ED9DE46-D04D-406A-BA77-02EC697D464EQ36054158-29AB88F2-FE28-4DDE-84BD-EF7A954474A2Q36170527-7690EF80-BFF9-40B9-BF90-D81FCD1DCABCQ36732596-7517FBCD-6945-4FAB-A075-179FC5794444Q36786862-7C942E78-0364-4EAD-85E4-0729ED0AA2EDQ36975194-B44F3BBD-6676-421C-BC54-C9ADECD861D4Q37065678-C2FDA355-3C99-4293-8998-470F94CF81E7Q37192198-8C1D4CD6-3D8F-4B8C-A5C9-06F530F80CFDQ37339194-9801C58F-D3B4-48E3-8B56-DBB351C4F326Q37415110-7CDF35F3-A059-46CA-8F91-4B2A3DC516ADQ37847257-E2D4BDFC-E974-42C6-9601-A67A537C0ACFQ37982341-7A5B2148-D154-4553-929C-AB1BEA138F60Q39804308-0595C3FF-1A53-4893-809C-448BBFF15F13Q40385561-D70D2C88-13B9-401A-9A54-C6B22BB6D7E0Q41037020-6915421E-BDBF-41D7-88ED-3F1AB4FA5BE4Q41812386-02530CDE-BAF6-4EA7-B6A4-337B1A85AE55Q43089380-4F41E505-61DC-4A78-8E56-3FCC379F565BQ47575408-5EAD2827-CA44-41A7-9D87-668AF2D1B7C9
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An RCAS-TVA-based approach to designer mouse models.
@ast
An RCAS-TVA-based approach to designer mouse models.
@en
An RCAS-TVA-based approach to designer mouse models.
@nl
type
label
An RCAS-TVA-based approach to designer mouse models.
@ast
An RCAS-TVA-based approach to designer mouse models.
@en
An RCAS-TVA-based approach to designer mouse models.
@nl
prefLabel
An RCAS-TVA-based approach to designer mouse models.
@ast
An RCAS-TVA-based approach to designer mouse models.
@en
An RCAS-TVA-based approach to designer mouse models.
@nl
P1433
P1476
An RCAS-TVA-based approach to designer mouse models.
@en
P2093
Sandra Orsulic
P2888
P304
P356
10.1007/S00335-002-4003-4
P577
2002-10-01T00:00:00Z